logo
episode-header-image
Jul 2023
27m 2s

How Many Points Is a Shot of Wegovy?

bloomberg
About this episode

WeightWatchers is going all-in on trendy new anti-obesity drugs. The gamble might save the company—if it doesn’t kill it first. By Emma Court and Ellen Huet

See omnystudio.com/listener for privacy information.

Up next
Jan 9
The Startup Making Human Embryos With AI-Assisted Robots
Conceivable’s automated lab has helped bring 19 babies to life. Is it better at IVF than humans are? By Sarah FrierSee omnystudio.com/listener for privacy information. 
37m 40s
Dec 26
Erasing the Verdict: The Ongoing Shock of Trump’s Cocaine Kingpin Pardon
Donald Trump’s pardon of Juan Orlando Hernández, the former president of Honduras, toppled the capstone of one of the most ambitious narcotics investigations in the history of the Department of Justice. By Monte ReelSee omnystudio.com/listener for privacy information. 
1h 7m
Dec 5
India’s Digital Dream, Hacked
India’s digital revolution has exposed millions to a criminal dystopia. This is the story of a neurologist placed under “digital arrest”; a farmer promised a job that would set him up for life; a young man arranging mule bank accounts; and a newlywed who joins the crypto underwor ... Show More
1h 3m
Recommended Episodes
Jul 2023
One Thing: Weight Loss Drugs: Trend or Treatment?
A new group of drugs for type 2 diabetes and obesity have shown to be more effective for weight loss than any previous medications. Some medications like Ozempic and Wegovy have surged in popularity thanks in part to celebrity use. But who should be taking them? And are they safe ... Show More
17m 14s
Apr 2023
Those New Obesity Drugs Really Work–If You Can Afford Them
Pharmaceutical companies and insurance providers are at odds over a new class of drugs that have proven quite effective at helping people living with obesity lose weight. Bloomberg’s Robert Langreth and Emma Court join this episode to share their reporting on recent advancements ... Show More
25m 18s
Apr 2023
Encore: Diet Wars | Dieting 3.0 | 5
<p>First there was Weight Watchers, then there was Noom, and now there’s…Wegovy? <em>Bloomberg</em> health reporter Emma Court helps us understand the evolution of dieting programs and where they’re going next. Later, Matthew Schnier of <em>New York Magazine</em> and <em>The Cut< ... Show More
39m 12s
Oct 2023
Semaglutide: Decoding the hype around the weight loss wonder drug
<p>From Elon Musk to several Hollywood celebrities, the weight loss wonder drug, semaglutide, is taking the world by storm. What was an unintended consequence of a diabetes control med, the emergence of significant weight loss has raised the expectation of the wonder drug becomin ... Show More
32m 7s
Feb 2024
The obesity drug craze is entering its next phase
Eli Lilly and Novo Nordisk can’t keep up with demand for their weight loss medications. In this Viewsroom podcast, Breakingviews columnists discuss the hype among celebrities, the different approaches to prescribing them in the US and Europe, and how they can reshape the world. V ... Show More
22m 46s
Sep 2023
2. The drug behind Europe's most valuable company
How much harm has been done by decades of governments investing too little? Is buy-now-pay-later causing misery or joy for young shoppers? Are supermarkets cutting prices fast enough? Is Novo Nordisk’s anti obesity wonder drug Semaglutide the most important pharmaceutical discove ... Show More
56m 39s
Sep 2023
iPhone Charging Gets a Makeover & Why Cold Medicines are Useless
Episode 146: Neal and Toby list off all the exciting tidbits from Apple's big product event, including the iPhone 15 reveal. Next, how a covid-era government program is affecting poverty rates in America. Plus, quick relief from a cold may be gone as FDA declares a key ingredient ... Show More
25m 26s